富士製薬工業(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4554/E00975-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2025/05/23日証協無担保3,400株0%0株0%5,350株-58.21%
2025/05/23日証協有担保332,303株-39.48%14,971株-65.81%37,166株-74.16%
2025/05/16日証協無担保0株-100%0株0%12,803株+411.92%
2025/05/16日証協有担保549,120株+160.27%43,791株+198.08%143,831株+10.81%
2025/05/09日証協無担保300株0%0株0%2,501株+177.58%
2025/05/09日証協有担保210,977株-5.01%14,691株-67.78%129,800株+252.72%
2025/05/02日証協無担保300株0%0株0%901株-30.75%
2025/05/02日証協有担保222,100株+85.65%45,591株-49.16%36,800株-5.15%
2025/04/25日証協無担保0株0%0株0%1,301株+62.62%
2025/04/25日証協有担保119,631株-58.67%89,682株+0.56%38,800株-49.13%
2025/04/18日証協無担保0株-100%0株0%800株-65.23%
2025/04/18日証協有担保289,468株+59.45%89,182株+40.26%76,266株-49.64%
2025/04/11日証協無担保800株-96.36%0株0%2,301株-92.7%
2025/04/11日証協有担保181,547株-50.91%63,582株+530.15%151,430株-32.85%
2025/04/04日証協無担保22,000株-2.22%0株0%31,512株-67.1%
2025/04/04日証協有担保369,814株+17.35%10,090株-91.03%225,500株+455.42%
2025/03/28日証協無担保22,500株+1223.53%0株0%95,794株+9469.83%
2025/03/28日証協有担保315,144株+122.05%112,493株-14.94%40,600株+14.93%
2025/03/21日証協無担保1,700株-26.09%0株-100%1,001株-37.44%
2025/03/21日証協有担保141,922株+53.5%132,244株+87.89%35,325株-61.77%
2025/03/14日証協無担保2,300株0%200株0%1,600株-70.38%
2025/03/14日証協有担保92,460株-52.56%70,382株+83.33%92,392株+58.75%
2025/03/07日証協無担保0株0%0株0%5,402株-57.8%
2025/03/07日証協有担保194,887株-37.88%38,391株+72.93%58,200株-42.79%
2025/02/28日証協無担保0株0%0株0%12,802株+299.06%
2025/02/28日証協有担保313,738株+67.06%22,200株-47.51%101,733株+364.53%
2025/02/21日証協無担保0株-100%0株0%3,208株-53.51%
2025/02/21日証協有担保187,796株-45.82%42,291株-63.44%21,900株-69.92%
2025/02/14日証協無担保500株0%0株0%6,901株-10.52%
2025/02/14日証協有担保346,606株+48.77%115,682株+104.2%72,816株+32.63%
2025/02/07日証協無担保0株-100%0株0%7,712株+305.89%
2025/02/07日証協有担保232,975株+0.98%56,652株-28.59%54,900株-15.41%
2025/01/31日証協無担保100株-80%0株0%1,900株-36.73%
2025/01/31日証協有担保230,716株+76.85%79,329株+223.73%64,900株+93.33%
2025/01/24日証協無担保500株0%0株0%3,003株+1379.31%
2025/01/24日証協有担保130,460株-38.5%24,505株-46.64%33,569株-57.67%
2025/01/17日証協無担保0株0%0株0%203株-96.24%
2025/01/17日証協有担保212,118株-24.49%45,923株-41.93%79,298株-38.32%

※株式分割は考慮していませんのでご注意ください。

Page Top